Evidence map›Paper›PMID 34899389›Full record

ReviewFrontiers in physiology2021

Sirtuin Oxidative Post-translational Modifications.

Kelsey S Kalous, Sarah L Wynia-Smith, Brian C Smith

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. The first and second zinc finger domains from Poly-ADP-ribose polymerase 1 (PARP1) are modified by hydrogen sulfide.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Article
  3. Review
  4. Review
  5. HBiochemistry · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Fundamentals of redox regulation in biology.Nature reviews. Molecular cell biology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Pharmacological Action and Research Progress of Taraxasterol.Current pharmaceutical biotechnology · 2024
    Review
  17. Epithelial NADFrontiers in immunology · 2023
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kelsey S KalousDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States.
Sarah L Wynia-SmithDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States.
Brian C SmithDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States.
Medical College of Wisconsin · US

Funding

Biochemical mechanisms of beta cell protection through bromodomain inhibitionR01DK119359 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI Brian Christopher Smith · 2018 to 2026
$3.1M
Sirt6 NAD+-Dependent Protein Deacetylase Inhibition by Cysteine S-nitrosationF31DK117588 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI KALOUS, KELSEY SHEA · 2018 to 2020
$110k
NIDDK NIH HHS F31 DK117588NIDDK NIH HHS R01 DK119359
6 · The paper itself

Abstract

Increased sirtuin deacylase activity is correlated with increased lifespan and healthspan in eukaryotes. Conversely, decreased sirtuin deacylase activity is correlated with increased susceptibility to aging-related diseases. However, the mechanisms leading to decreased sirtuin activity during aging are poorly understood. Recent work has shown that oxidative post-translational modification by reactive oxygen (ROS) or nitrogen (RNS) species results in inhibition of sirtuin deacylase activity through cysteine nitrosation, glutathionylation, sulfenylation, and sulfhydration as well as tyrosine nitration. The prevalence of ROS/RNS (e.g., nitric oxide,

Indexed as

glutathionylationnitrationnitrosationnitrosylationoxidationsirtuin (SIRT)sulfenylationsulfhydration

Identifiers

PMID34899389
PMCPMC8652059
OpenAlexW3214761819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.